Abbreviations as in Figure S1 . The P values were calculated using the log-rank test on the basis of all available follow-up data with always users as reference.
Abbreviations as in Figure S1 . MACCE indicates major adverse cardiac and cerebrovascular events.
Supplemental Methods

Revascularization procedures
As part of standard institutional requirements, all surgeons had to have specialized in congenital or valve heart surgery for more than 3 years before undertaking any CABG procedures. With respect to off-pump CABG, the surgeon had to perform at least 100 on-pump CABG procedures before being considered qualified to carry out the off-pump procedure. Once qualified, the choice of off-pump CABG as opposed to on-pump CABG for a particular patient was generally at the discretion of the individual surgeons.
Anesthesia was managed by inhalation of isoflurane with the addition of fentanyl or sufentanil, and propofol was administered continuously until the end of the procedure if necessary. Surgical revascularization was performed using standard bypass techniques. For on-pump CABG, a standard cardiopulmonary bypass was established, and moderate systemic hypothermia (28°C to 32°C) and perfusion with antegrade intermittent cold crystalloid cardioplegia were used. Heparin was given to achieve activated clotting times of 480 seconds or above before institution of cardiopulmonary bypass. For off-pump CABG, stabilization devices were used to provide a motionless anastomosis site, and heparin was administered before the start of the first distal anastomosis to achieve an activated clotting time of 300 to 350 seconds. On-pump CABG involved aortic cross-clamping and cardioplegic arrest, while off-pump CABG was performed with a partial occlusion clamp. Whenever possible, complete revascularization was attempted, and the internal thoracic artery was used preferentially for revascularization of the left anterior descending artery. The remaining vessels were to be bypassed either using another arterial conduit or the saphenous vein in the configuration decided by the surgeon. During reperfusion, the 4 bypass grafting was completed with proximal anastomoses to the ascending aorta. The decision to switch to cardiopulmonary bypass during the procedure was based on significant hemodynamic instability or ventricular arrhythmia. After separation from cardiopulmonary bypass or on completion of all anastomoses, protamine was given to reverse the effects of heparin. Postoperatively, starting within the first 24 hours, aspirin therapy (100 mg/d) is recommended and should be continued indefinitely.
Definitions
Death was defined as death from any cause.
Myocardial infarction occurred when there were clinical signs and symptoms of ischemia that were distinct from the presenting ischemic event and meeting at least 1 of the following criteria:
1. Spontaneous (before or without revascularization, >48 h after CABG):
A. New, significant Q waves in at least 2 contiguous leads of an ECG that were not present with the presenting ischemic event;
B. Patients whose most recent cardiac markers measured before reinfarction, which were normal, require an increase in CK-MB or troponin that is above the 99 th percentile upper limit of normal and at least ≥20% above the most recent value.
Within 48 h after CABG:
A CABG-related MI was defined by elevation of cardiac biomarker values >10 
Supplemental Tables
Supplemental Table S1 . Candidate Risk Factors BMI indicates body mass index; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; CVA, cerebrovascular accident; CHF, chronic heart failure; PCI, percutaneous coronary intervention; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; MI, myocardial infarction; IABP, intra-aortic balloon pump; LIMA, left internal mammary artery; LAD, left anterior descending; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.
*Calculated as weight in kilograms divided by height in meters squared. †Previous MI was included in the overall cohorts and in the propensity score calculation as a covariate in the matched cohorts. ‡An index of completeness of revascularization (ICOR) was defined as the ratio of the total number of distal vessels bypassed to the number of diseased territories reported on the preoperative coronary angiographic results. A revascularization with an ICOR ≥1 was considered complete revascularization. §Year of surgery was included in the multivariable regression model as each class indicating a calendar of year. ¶Surgeons were grouped into turtles according to the surgical volume (<250 cases, 250-500 cases, and >500 cases). Table S1 .
Risk Factors
Values expressed as number (percentage) hsCRP, mg/L* 3.1 (3.6) 3.4 (3.8) 3.1 (3.7)
Procedural characteristics
Grafts per patient, mean (SD), n 3.4 (0.9) 3.3 (0.9) 3.1 (0.9)
Off-pump procedure 1426 (49) 1083 (64) 1133 (86) LIMA-to-LAD graft 2788 (95) 1590 (95) 1244 (94) Complete revascularization 2708 (93) 1535 (91) 1160 (88) Supplemental Abbreviations as in Table S1 .
Values expressed as percentage unless otherwise indicated. 
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